QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 限定条件 内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Long-Term Follow-up of Peginterferon alpha-2b (40kD, Y Shape) (Pegberon) Treatment of Hbeag-Positive Chronic Hepatitis B Patients in Phase III Study 会议论文 作者:  Wang, Guiqiang;  Hou, Fengqin;  Zhang, Mingxiang;  Zhang, Dazhi;  Peng, Yanzhong 收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05 Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 会议论文 作者:  Cheng, Jun;  Yu, Yanyan;  Wang, Hao;  Xu, Min;  Shi, Guangfeng 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 会议论文 作者:  Sun, Jian;  Yuan, Quan;  Xie, Qing;  Fan, Rong;  Tan, Deming 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/19 FACTORS ASSOCIATED WITH SERUM HBSAG LEVELS IN CHRONIC HEPATITIS B VIRUS INFECTION IN CHINESE PATIENTS 会议论文 61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, OCT 29-NOV 02, 2010 作者:  Li, Qiang;  Xie, Shuangshuang;  Yu, Jinhong;  Fan, Wenbo;  Li, Wenwen 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/31 ON-TREATMENT QUANTIFICATION OF HBSAG IN DIFFICULT-TO-TREAT PATIENTS WITH LAMIVUDINE RESISTANCE CAN HELP IDENTIFY THOSE MOST LIKELY TO ACHIEVE SUSTAINED POST-TREATMENT RESPONSE TO PEGINTERFERON ALFA-2A RESCUE THERAPY 会议论文 作者:  Hou, Jinlin;  Sun, Jian;  Xie, Qing;  Li, Xiuhui;  Zhang, Jiming 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2A VERSUS ADEFOVIR DIPIVOXIL (ADV) IN TREATING LAMIVUDINE RESISTANT HBEAG POSITIVE CHB: AN INTERIM ANALYSIS OF A PROSPECTIVE RANDOMIZED STUDY 会议论文 作者:  Hou, Jinlin;  Sun, Jian;  Xie, Qing;  Li, Xiuhui;  Zhong, Jiming 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19